|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 | |
网站主页 >> 化工产品目录 >> GPR40 Activator 2>> 市场分析报告 |
GPR40 Activator 2市场分析报告 |
|
Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) - Pipeline Review, H2 2018 ... Receptor 40 or GPR40 or FFAR1) targeted therapeutics development with respective active and ... collaboration details & other developmental activities The report reviews key ... 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) targeted therapeutics based on ... Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) – Pipeline Review, H1 2018 ... Receptor 40 or GPR40 or FFAR1) targeted therapeutics development with respective active and ... collaboration details & other developmental activities The report reviews key ... 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) targeted therapeutics based on ... Free Fatty Acid Receptor 1 - Pipeline Review, H2 2020 ... Receptor 40 or GPR40 or FFAR1) targeted therapeutics development with respective active and ... collaboration details & other developmental activities The report reviews key ... 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) targeted therapeutics based on ... Free Fatty Acid Receptor 1 - Pipeline Review, H1 2020 ... Receptor 40 or GPR40 or FFAR1) targeted therapeutics development with respective active and ... collaboration details & other developmental activities The report reviews key ... 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) targeted therapeutics based on ... Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update ... Receptor 40 or GPR40 or FFAR1) targeted therapeutics development with respective active and ... collaboration details & other developmental activities The report reviews key ... 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) targeted therapeutics based on ... Free Fatty Acid Receptor 1 - Drugs In Development, 2021 ... Receptor 40 or GPR40 or FFAR1) targeted therapeutics development with respective active and ... collaboration details & other developmental activities The report reviews key ... 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) targeted therapeutics based on ... Competitor Analysis: Targeted Therapy of Diabetes ... report includes a compilation of currently active projects in research and development of ... AMPK) Agonists Sirtuin (SIRT) Activators Protein tyrosine Phosphatase-1B (PTP-1B) Inhibitors ... Drugs Augmenting GLP-1 Secretion: GPR40, GPR120 & TGR5 Agonists Other ... Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Neuropathy - Drugs In Development, 2022, ... India Pharma Outlook 2015: Accelerating Growth to the Next Level: Moving up the Value Chain Beyond Generics Domestic sales improved in 2014, recovering from the slump in the 2013 caused by the market’s reaction to the new drug pricing policy. In 2015, growth is expected to continue to be healthy, as the momentum continues and improving economic growth allow more ... Competitor Analysis: Emerging Diabetes Drugs ... report includes a compilation of currently active projects in research and development ... HSD1) Inhibitors Glucokinase Activators (GKA) Adenosine Monophosphate Activated Protein Kinase (AMPK ... Drugs Augmenting GLP-1 Secretion: GPR40, GR120 & TGR5 Agonists Other ... |